-transparent.png){kind=logo}
Renal cell carcinoma (RCC) accounts for 2% of all human cancer, but familial cases are infrequent. Riches (1963) and Griffin et al. (1984) in a population-based case-control study found a family history of renal cell carcinoma in 2.4% of affected patients compared to 1.4% of controls. Nevertheless the importance of inherited tumours in clinical practice and medical research is disproportionate to their frequency. In clinical practice recognition of familial RCC can provide opportunities to prevent morbidity and mortality by appropriate screening. In medical research recent advances in molecular genetics offer the prospect of isolating the genes involved in the pathogenesis of familial RCC and of the more common sporadic cases. In this article we review the clinical and molecular genetics of inherited renal cell carcinoma (adenocarcinoma or hypernephroma).
E R Maher, and
J R Yates
May 1993,
The Urologic clinics of North America,
E R Maher, and
J R Yates
April 2000,
Seminars in oncology,
E R Maher, and
J R Yates
July 2018,
Indian journal of clinical biochemistry : IJCB,
E R Maher, and
J R Yates
November 2000,
Pathology international,
E R Maher, and
J R Yates
May 2022,
Urologiia (Moscow, Russia : 1999),
E R Maher, and
J R Yates
August 2016,
Applied immunohistochemistry & molecular morphology : AIMM,
E R Maher, and
J R Yates
June 2005,
Clinics in laboratory medicine,
E R Maher, and
J R Yates
May 2024,
The American journal of surgical pathology,
E R Maher, and
J R Yates
July 2015,
Endocrine regulations,
E R Maher, and
J R Yates
April 2006,
Histology and histopathology,
